Research into Cancer, Diabetes, and Other Diseases Puts Spotlight on Clinical Proteomics at HUPO
October 01, 2009
Research into Cancer, Diabetes, and Other Diseases Puts Spotlight on Clinical Proteomics at HUPO
Clinical proteomics may have a spotty and troubled history, but at the Human Proteome Organization's annual conference in Toronto, the push to move proteomics from the research lab to the clinical setting was everywhere to be seen.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Human Proteome Project Revisited at HUPO; Methodology, Funding, Data Management Still Open Questions
October 1, 2009 / ProteoMonitor - Caprion Identifies Protein Biomarkers for Predicting Patient Response to New Hepatitis C Drug
October 22, 2010 / ProteoMonitor - Agilent and Integrated Diagnostics Partner on Protein Biomarker Assays
January 10, 2012 / GenomeWeb Daily News - Q&A: Denis Hochstrasser on Missed Clinical Opportunities for Proteomics
October 28, 2011 / ProteoMonitor - Teams Publish Proof-of-Principle Studies on Targeted Mass Spec-Based Biomarker Pipelines
June 20, 2011 / GenomeWeb Daily News